Intelligent Common Stock from 2010 to 2025

INBS Stock

USD 2.16 0.07 3.35%

Intelligent Bio Common Stock yearly trend continues to be comparatively stable with very little volatility. Common Stock will likely drop to about 29.5 K in 2025. From the period from 2010 to 2025, Intelligent Bio Common Stock quarterly data regression had r-value of 0.12 and coefficient of variation of 254.18. View All Fundamentals

Common Stock

First Reported

2018-06-30

Previous Quarter

43.8 K

Current Value

48.1 K

Quarterly Volatility

984.1 K

Covid

Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 142.9 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 2.05, Dividend Yield of 0.0 or PTB Ratio of 0.66. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.

Check out the analysis of Intelligent Bio Correlation against competitors.

Latest Intelligent Bio's Common Stock Growth Pattern

Below is the plot of the Common Stock of Intelligent Bio Solutions over the last few years. It is Intelligent Bio's Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.

Common Stock

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Common Stock

Timeline

Intelligent Common Stock Regression Statistics

	Arithmetic Mean	325,609
	Geometric Mean	362.05
	Coefficient Of Variation	254.18
	Mean Deviation	518,598
	Median	23,304
	Standard Deviation	827,634
	Sample Variance	685B
	Range	2.9M
	R-Value	0.12
	Mean Square Error	724.1B
	R-Squared	0.01
	Significance	0.67
	Slope	20,134
	Total Sum of Squares	10.3T

Intelligent Common Stock History

	2025	29.5 K
	2024	31.1 K
	2023	34.6 K
	2022	23.3 K
	2021	148.9 K
	2020	142.3 K
	2019	2.9 M

Intelligent Bio Common Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Deferred Long Term Liab	Property Plant Equipment	Long Term Debt	Short Term Investments	Intangible Assets
Total Assets		0.97	-0.94	-0.83	0.77	-0.4	0.96	-0.87	-0.15	0.89	0.93	0.95	-0.93	-0.92	0.92	0.64	-0.3	0.6	-0.3	-0.3	-0.49
Total Stockholder Equity	0.97		-0.95	-0.87	0.74	-0.52	0.93	-0.9	-0.2	0.87	0.91	0.99	-0.96	-0.96	0.9	0.72	-0.5	0.63	-0.5	-0.5	-0.64
Net Debt	-0.94	-0.95		0.72	-0.68	0.4	-0.97	0.9	0.28	-0.96	-0.92	-0.94	0.9	0.9	-0.98	-0.64	0.33	-0.41	0.33	0.33	0.45
Retained Earnings	-0.83	-0.87	0.72		-0.64	0.56	-0.7	0.77	0.03	-0.6	-0.77	-0.88	0.92	0.91	-0.6	-0.81	0.52	-0.85	0.52	0.52	0.73
Accounts Payable	0.77	0.74	-0.68	-0.64		-0.03	0.72	-0.66	0.12	0.74	0.78	0.74	-0.74	-0.72	0.7	0.32	-0.19	0.4	-0.19	-0.19	-0.18
Total Liab	-0.4	-0.52	0.4	0.56	-0.03		-0.36	0.44	0.46	-0.25	-0.19	-0.53	0.51	0.56	-0.31	-0.74	0.64	-0.56	0.64	0.64	0.76
Total Current Assets	0.96	0.93	-0.97	-0.7	0.72	-0.36		-0.79	-0.1	0.96	0.93	0.9	-0.85	-0.84	0.98	0.59	-0.26	0.38	-0.26	-0.26	-0.4
Short Term Debt	-0.87	-0.9	0.9	0.77	-0.66	0.44	-0.79		0.49	-0.82	-0.81	-0.94	0.94	0.95	-0.82	-0.7	0.4	-0.62	0.4	0.4	0.52
Common Stock	-0.15	-0.2	0.28	0.03	0.12	0.46	-0.1	0.49		-0.18	0.02	-0.29	0.25	0.32	-0.23	-0.2	0.13	-0.21	0.13	0.13	0.17
Net Receivables	0.89	0.87	-0.96	-0.6	0.74	-0.25	0.96	-0.82	-0.18		0.92	0.86	-0.82	-0.81	0.97	0.54	-0.2	0.23	-0.2	-0.2	-0.24
Net Tangible Assets	0.93	0.91	-0.92	-0.77	0.78	-0.19	0.93	-0.81	0.02	0.92		0.89	-0.89	-0.86	0.89	0.6	-0.27	0.43	-0.27	-0.27	-0.36
Net Invested Capital	0.95	0.99	-0.94	-0.88	0.74	-0.53	0.9	-0.94	-0.29	0.86	0.89		-0.98	-0.98	0.88	0.75	-0.49	0.67	-0.49	-0.49	-0.63
Short Long Term Debt	-0.93	-0.96	0.9	0.92	-0.74	0.51	-0.85	0.94	0.25	-0.82	-0.89	-0.98		1.0	-0.81	-0.79	0.45	-0.71	0.45	0.45	0.6
Capital Stock	-0.92	-0.96	0.9	0.91	-0.72	0.56	-0.84	0.95	0.32	-0.81	-0.86	-0.98	1.0		-0.8	-0.79	0.46	-0.72	0.46	0.46	0.61
Net Working Capital	0.92	0.9	-0.98	-0.6	0.7	-0.31	0.98	-0.82	-0.23	0.97	0.89	0.88	-0.81	-0.8		0.5	-0.24	0.28	-0.24	-0.24	-0.34
Current Deferred Revenue	0.64	0.72	-0.64	-0.81	0.32	-0.74	0.59	-0.7	-0.2	0.54	0.6	0.75	-0.79	-0.79	0.5		-0.61	0.67	-0.61	-0.61	-0.74
Deferred Long Term Liab	-0.3	-0.5	0.33	0.52	-0.19	0.64	-0.26	0.4	0.13	-0.2	-0.27	-0.49	0.45	0.46	-0.24	-0.61		-0.47	1.0	1.0	0.85
Property Plant Equipment	0.6	0.63	-0.41	-0.85	0.4	-0.56	0.38	-0.62	-0.21	0.23	0.43	0.67	-0.71	-0.72	0.28	0.67	-0.47		-0.47	-0.47	-0.75
Long Term Debt	-0.3	-0.5	0.33	0.52	-0.19	0.64	-0.26	0.4	0.13	-0.2	-0.27	-0.49	0.45	0.46	-0.24	-0.61	1.0	-0.47		1.0	0.85
Short Term Investments	-0.3	-0.5	0.33	0.52	-0.19	0.64	-0.26	0.4	0.13	-0.2	-0.27	-0.49	0.45	0.46	-0.24	-0.61	1.0	-0.47	1.0		0.85
Intangible Assets	-0.49	-0.64	0.45	0.73	-0.18	0.76	-0.4	0.52	0.17	-0.24	-0.36	-0.63	0.6	0.61	-0.34	-0.74	0.85	-0.75	0.85	0.85

Click cells to compare fundamentals

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as Common Stock, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Common Stock	31.1 K	29.5 K
Common Stock Shares Outstanding	3.7 M	3.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Intelligent Common Stock from 2010 to 2025

Latest Intelligent Bio's Common Stock Growth Pattern

Intelligent Common Stock Regression Statistics

Intelligent Common Stock History

Other Fundumenentals of Intelligent Bio Solutions

Intelligent Bio Common Stock component correlations

About Intelligent Bio Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Intelligent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY